Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FG4RA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,280.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,280 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Kisqali 600 mg daily dose (63 tablets). Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 11, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FG4RA?
SPE2DR26FG4RA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 18, 2026.
How much is contract SPE2DR26FG4RA worth?
The government has obligated $12,280 on SPE2DR26FG4RA.
Is contract SPE2DR26FG4RA an order under another contract?
Yes. SPE2DR26FG4RA is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG4RA competed?
The extent of competition for SPE2DR26FG4RA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award